NCT06942741View on ClinicalTrials.gov

A Study to Evaluate the Effect of Formulation and Food on MK-1084 in Healthy Adult Participants (MK-1084-011)

PHASE1CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

June 22, 2025

Study Completion Date

August 4, 2025

Conditions

Healthy

Interventions

DRUG

MK-1084 OCT

Oral tablet

DRUG

MK-1084 FCT

Oral tablet

Trial Locations (1)

85283

Celerion ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY